Alopecia - Pipeline Review, H1 2015

Publisher Name :
Date: 30-Jan-2015
No. of pages: 68
Inquire Before Buying

Global Markets Direct's, ‘Alopecia - Pipeline Review, H1 2015', provides an overview of the Alopecia's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Alopecia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Alopecia and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope


  • The report provides a snapshot of the global therapeutic landscape of Alopecia

  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

  • The report reviews key players involved in the therapeutics development for Alopecia and enlists all their major and minor projects

  • The report summarizes all the dormant and discontinued pipeline projects

  • A review of the Alopecia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

  • A detailed assessment of monotherapy and combination therapy pipeline projects

  • Coverage of the Alopecia pipeline on the basis of target, MoA, route of administration and molecule type

  • Latest news and deals relating related to pipeline products


Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Develop strategic initiatives by understanding the focus areas of leading companies

  • Identify and understand important and diverse types of therapeutics under development for Alopecia

  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

  • Devise corrective measures for pipeline projects by understanding Alopecia pipeline depth and focus of Indication therapeutics

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Alopecia - Pipeline Review, H1 2015

Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Alopecia Overview 8
Therapeutics Development 9
Pipeline Products for Alopecia - Overview 9
Pipeline Products for Alopecia - Comparative Analysis 10
Alopecia - Therapeutics under Development by Companies 11
Alopecia - Therapeutics under Investigation by Universities/Institutes 13
Alopecia - Pipeline Products Glance 14
Late Stage Products 14
Clinical Stage Products 15
Early Stage Products 16
Alopecia - Products under Development by Companies 17
Alopecia - Products under Investigation by Universities/Institutes 18
Alopecia - Companies Involved in Therapeutics Development 19
AndroScience Corporation 19
Bristol-Myers Squibb Company 20
C3 Jian, Inc 21
Follicum AB 22
Kuhnil Pharmaceutical Co., Ltd. 23
Lee's Pharmaceutical Holdings Limited 24
Panacea Biotec Limited 25
ProCertus BioPharm Inc. 26
Taisho Pharmaceutical Co., Ltd. 27
Tigo GmbH 28
Vida Therapeutics Inc. 29
Alopecia - Therapeutics Assessment 30
Assessment by Monotherapy Products 30
Assessment by Target 31
Assessment by Mechanism of Action 33
Assessment by Route of Administration 35
Assessment by Molecule Type 37
Drug Profiles 39
abatacept (recombinant) - Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
ASCJ-9 - Drug Profile 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
calcitriol - Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
DHL-HisZnNa - Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
interferon beta-1b - Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
KI-1104 - Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
KI-1105 - Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
Peptide for Alopecia - Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
Peptide for Alopecia and Chemotherapy Effects - Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
ProDermaCel - Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
Recombinant Peptides for Alopecia - Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
Recombinant Proteins to Antagonize IFN-Gamma Receptor for Alopecia Areata and Graft Arteriosclerosis - Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
Small Molecule to Inhibit ALK5 for Alopecia and Fibrosis - Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
Small Molecules to Activate P2Y5 Receptor for Alopecia - Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
Small Molecules to Inhibit Plasminogen Activator Inhibitor-1 for Thromboembolic Disease, PCOS and Alopecia - Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
V-2248 - Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
ZK-003 - Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
Alopecia - Recent Pipeline Updates 60
Alopecia - Dormant Projects 63
Alopecia - Discontinued Products 65
Alopecia - Product Development Milestones 66
Featured News & Press Releases 66
Jul 23, 2012: Berg Pharma Launches Clinical Trial On BPM 31543 For Prevention Of Chemotherapy-induced Alopecia 66
Appendix 67
Methodology 67
Coverage 67
Secondary Research 67
Primary Research 67
Expert Panel Validation 67
Contact Us 67
Disclaimer 68

List of Tables

Number of Products under Development for Alopecia, H1 2015 9
Number of Products under Development for Alopecia - Comparative Analysis, H1 2015 10
Number of Products under Development by Companies, H1 2015 12
Number of Products under Investigation by Universities/Institutes, H1 2015 13
Comparative Analysis by Late Stage Development, H1 2015 14
Comparative Analysis by Clinical Stage Development, H1 2015 15
Comparative Analysis by Early Stage Development, H1 2015 16
Products under Development by Companies, H1 2015 17
Products under Investigation by Universities/Institutes, H1 2015 18
Alopecia - Pipeline by AndroScience Corporation, H1 2015 19
Alopecia - Pipeline by Bristol-Myers Squibb Company, H1 2015 20
Alopecia - Pipeline by C3 Jian, Inc, H1 2015 21
Alopecia - Pipeline by Follicum AB, H1 2015 22
Alopecia - Pipeline by Kuhnil Pharmaceutical Co., Ltd., H1 2015 23
Alopecia - Pipeline by Lee's Pharmaceutical Holdings Limited, H1 2015 24
Alopecia - Pipeline by Panacea Biotec Limited, H1 2015 25
Alopecia - Pipeline by ProCertus BioPharm Inc., H1 2015 26
Alopecia - Pipeline by Taisho Pharmaceutical Co., Ltd., H1 2015 27
Alopecia - Pipeline by Tigo GmbH, H1 2015 28
Alopecia - Pipeline by Vida Therapeutics Inc., H1 2015 29
Assessment by Monotherapy Products, H1 2015 30
Number of Products by Stage and Target, H1 2015 32
Number of Products by Stage and Mechanism of Action, H1 2015 34
Number of Products by Stage and Route of Administration, H1 2015 36
Number of Products by Stage and Molecule Type, H1 2015 38
Alopecia Therapeutics - Recent Pipeline Updates, H1 2015 60
Alopecia - Dormant Projects, H1 2015 63
Alopecia - Dormant Projects (Contd..1), H1 2015 64
Alopecia - Discontinued Products, H1 2015 65

List of Figures

Number of Products under Development for Alopecia, H1 2015 9
Number of Products under Development for Alopecia - Comparative Analysis, H1 2015 10
Number of Products under Development by Companies, H1 2015 11
Number of Products under Investigation by Universities/Institutes, H1 2015 13
Comparative Analysis by Clinical Stage Development, H1 2015 15
Comparative Analysis by Early Stage Products, H1 2015 16
Assessment by Monotherapy Products, H1 2015 30
Number of Products by Top 10 Targets, H1 2015 31
Number of Products by Stage and Top 10 Targets, H1 2015 32
Number of Products by Top 10 Mechanism of Actions, H1 2015 33
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 34
Number of Products by Top 10 Routes of Administration, H1 2015 35
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 36
Number of Products by Top 10 Molecule Types, H1 2015 37
Number of Products by Stage and Top 10 Molecule Types, H1 2015 38

  • Autoimmune Drugs Industry Forecasts - China Focus
    Published: 11-Oct-2019        Price: US 1800 Onwards        Pages: 78
    This study focuses on China's Autoimmune Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services. Th......
  • Autoimmune Drugs Companies in China
    Published: 11-Oct-2019        Price: US 1800 Onwards        Pages: 71
    This study focuses on China's Autoimmune Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of......
  • Autoimmune Drugs Markets in China
    Published: 11-Oct-2019        Price: US 4000 Onwards        Pages: 201
    China's demand for Autoimmune Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, indu......
  • Global Autoimmune Drugs Market Professional Survey Report 2019
    Published: 25-Sep-2019        Price: US 3500 Onwards        Pages: 107
    Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental ......
  • Global Autoimmune Drug Industry Market Research Report
    Published: 30-Aug-2019        Price: US 2960 Onwards        Pages: 122
    The Autoimmune Drug market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Autoimmune Drug industrial chain, this report mainly elaborates the definition, types, applications and major players of Autoimmune Drug market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry developme......
  • Global (United States, European Union and China) Systemic Lupus Erythematosus (SLE) Drugs Market Research Report 2019-2025
    Published: 20-Aug-2019        Price: US 3280 Onwards        Pages: 119
    SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces autoantibodies, which attack and destroy healthy tissues in the body rather than foreign infectious agents. These autoantibodies cause inflammation, pain, and damage. It is also known as a disease of ......
  • Global (United States, European Union and China) Autoimmune Drugs Market Research Report 2019-2025
    Published: 09-Aug-2019        Price: US 3280 Onwards        Pages: 116
    Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental ......
  • Global Systemic Lupus Erythematosus (Sle) Drugs Industry Market Research Report
    Published: 11-Jul-2019        Price: US 2960 Onwards        Pages: 111
    The Systemic Lupus Erythematosus (Sle) Drugs market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Systemic Lupus Erythematosus (Sle) Drugs industrial chain, this report mainly elaborates the definition, types, applications and major players of Systemic Lupus Erythematosus (Sle) Drugs market in details. Deep analysis about market status (2014-2019), enterprise competition patte......
  • Global Systemic Lupus Erythematosus (SLE) Drugs Market Insights, Forecast to 2025
    Published: 31-May-2019        Price: US 3900 Onwards        Pages: 117
    SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces autoantibodies, which attack and destroy healthy tissues in the body rather than foreign infectious agents. These autoantibodies cause inflammation, pain, and damage. It is also known as a disease of ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs